EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NGS amplification panel HCV-seq for sequencing hepatitis C virus RNA (Flaviviridae: Hepacivirus)

M D Chanyshev iD, A S Chernyshova iD, A G Glushchenko iD, A A Grishaeva iD, V V Makashova iD, Z B Ponezheva iD, K F Khafizov iD, V G Akimkin iD

Problems of Virology · 16.09.2025 · 70 (4) · 363-373

DOI: 10.36233/0507-4088-331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Problems of Virology, online erschienen am 16.09.2025. Verfasst von M D Chanyshev und 7 weiteren Autor:innen. Beteiligte Einrichtung: Central Research Institute of Epidemiology. Hauptthemen laut MEDLINE: Hepacivirus, Genome, Viral, RNA, Viral, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatitis C is a pressing global public health issue. The high variability of the hepatitis C virus (HCV) complicates its whole-genome sequencing; most studies sequence only specific regions of the genome. There is a need for a simple and reliable method for sequencing the whole genome of HCV.

Objective

Development and validation of NGS panel for whole-genome sequencing of HCV. Materials and methods. This study presents NGS amplification panel for sequencing the genomes of HCV genotypes 1, 2, and 3. Depending on the genotype, a set of 79, 67, or 89 primers is used. These primers enable amplification of overlapping regions of the HCV genome.

Results

The panel was tested on 153 HCV RNA samples isolated from blood plasma specimens (93/6/54 samples of genotypes 1/2/3, respectively). Shannon entropy analysis showed that genetic heterogeneity within the E2 gene is significantly higher than in other parts of viral genome. The frequency of mutations associated with drug resistance was determined. Specifically, for genotype 1, the following mutation detection rates were observed in NS3: Y56F – 37.6%, V170I – 23.7%; in NS5a: R30Q – 8.6%, P58L/S/T – 6.5%, A92T – 4.3%; in NS5b: L159F – 45.2%, S556G/N – 33.3%.

Conclusion

The current study describes a method for whole-genome sequencing of HCV genotypes 1, 2, and 3. The HCV sequencing panel shows great potential for use in scientific research and epidemiological monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusGenome, ViralRNA, ViralHepatitis CHigh-Throughput Nucleotide SequencingViral Nonstructural ProteinsHumansGenotypeDrug Resistance, ViralMutationWhole Genome Sequencing

Stichwörter der Autor:innen

HCVNGSmutationswhole-genome sequencing

Substanzen

RNA, ViralViral Nonstructural Proteins

Autor:innen und Institutionen

  • Central Research Institute of Epidemiology.
  • Moscow Institute of Physics and Technology.

ORCID-Profile: M D Chanyshev, A S Chernyshova, A G Glushchenko, A A Grishaeva, V V Makashova, Z B Ponezheva, K F Khafizov, V G Akimkin

Zitieren

APA

Chanyshev, M. D., Chernyshova, A. S., Glushchenko, A. G., Grishaeva, A. A., Makashova, V. V., Ponezheva, Z. B., Khafizov, K. F., & Akimkin, V. G. (2025). NGS amplification panel HCV-seq for sequencing hepatitis C virus RNA (Flaviviridae: Hepacivirus). Problems of Virology, 70(4), 363-373. https://doi.org/10.36233/0507-4088-331

Vancouver

Chanyshev MD, Chernyshova AS, Glushchenko AG, Grishaeva AA, Makashova VV, Ponezheva ZB, et al. NGS amplification panel HCV-seq for sequencing hepatitis C virus RNA (Flaviviridae: Hepacivirus). Problems of Virology. 2025;70(4):363-373. doi:10.36233/0507-4088-331

BibTeX
@article{Chanyshev2025,
  author = {Chanyshev, M D and Chernyshova, A S and Glushchenko, A G and Grishaeva, A A and Makashova, V V and Ponezheva, Z B and Khafizov, K F and Akimkin, V G},
  title = {NGS amplification panel HCV-seq for sequencing hepatitis C virus RNA (Flaviviridae: Hepacivirus)},
  journal = {Problems of Virology},
  year = {2025},
  volume = {70},
  number = {4},
  pages = {363--373},
  doi = {10.36233/0507-4088-331}
}
Kostenlos starten →